83bar executive Kate Hermans to moderate a panel at SCOPE Summit 2020

- Ms. Hermans will exchange views on measuring patient empowerment in clinical trial recruitment
- Panel will cover vendor performance metrics and KPIs, as part of outsourcing and strategic partnerships in clinical trials
- Insights from 83bar experience using 4-step Patient Activation process in trial recruitment
By: 83bar, LLC
1 2
Kate Hermans, chief business officer/pharma, 83bar
Kate Hermans, chief business officer/pharma, 83bar
AUSTIN, Texas - Jan. 28, 2020 - PRLog -- Kate Hermans, chief business officer for pharma at 83bar LLC, will moderate a panel session on patient empowerment at the SCOPE Summit 2020 on February 18-21 in Orlando, FL.

Joining Ms. Hermans from 83bar is Evan Bingen, director of business development.

83bar has a fully integrated digital health technology platform for individualized patient activation at scale. The use of the platform for clinical trial recruitment has shown meaningful results for study sponsors, investigator sites, and patients.

Panel topics moderated by Ms. Hermans include:
  • How effective are KPIs for measuring vendor performance and quality?
  • What is strategy for establishing KPIs and metrics?
  • What are areas to evaluate vendor performance and quality?
  • Innovative approaches for patient empowerment in clinical trial process.
  • Improving patient experience and implications for development of new therapies and medical devices
The group facilitated by Ms. Hermans is an interactive discussion of key issues. Delegates bring their own pharma, CRO, site, hospital or patient perspectives. They share examples and vet new ideas among peers.


In its eleventh year, SCOPE Summit 2020 is February 18-21 in Orlando, FL. Over four days of discussions in 20 conferences, 3 plenary keynotes, Participant Engagement Awards, and interactive breakouts, the program focuses on advances and innovative solutions in clinical trial planning, management and operations, including: Site Management, Patient Engagement, Recruitment and Retention, Protocol Optimization, Feasibility, Data Analytics, Sensors and Wearables, Project Management, Outsourcing, Resource Management, Quality in Trial Conduct, Risk-Based Monitoring, Artificial Intelligence, Post-Marketing Studies, Observational Research, Accessing and Generating RWD, Medical Device Clinical Trial Operations, and more. SCOPE attracted over 2,000 leaders in clinical operations and research in 2019. Each conference track feature best practice case studies. More information at www.scopesummit.com

About 83bar, LLC

83bar, LLC, headquartered in Austin, Texas, is the leading patient activation marketing agency. 83bar has developed a system that has been implemented by more than three dozen name brands in health, medical, technology, and devices. The company has a database of more than one million patient engagements over the past five years. Its four-step activation process is a system integrated to LOCATE prospective patients through risk assessment and health surveys; EDUCATE them to offer solutions and help them make informed decisions; NAVIGATE patients to action by appointment scheduling or service fulfillment; and through comprehensive follow-up, convert these patients to ADVOCATE on behalf of improved treatment and health care. Contact at www.go83bar.com


Like PRLog?
Click to Share